This inventor holds 2 USPTO granted patents. Top assignee: Dainippon Pharmaceutical Company, Limited. Active years: 2003-2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2003-2004
Title: The Innovative Contributions of Tomoki Omodani
Introduction
Tomoki Omodani is a notable inventor based in Kawanishi, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that have potential applications in drug formulation. With a total of 2 patents to his name, Omodani's work is recognized for its innovative approach to drug discovery.
Latest Patents
Omodani's latest patents include groundbreaking work on heterocyclic compounds and intermediates that serve as elastase inhibitors. One of his notable inventions is a process for producing (aminomethyl)trifluoromethylcarbinol derivatives. This invention is particularly important as it provides a method for industrially producing optically active compounds that can be utilized as starting materials for drugs, including protease inhibitors.
Career Highlights
Tomoki Omodani is currently employed at Dainippon Pharmaceutical Company, Limited, where he continues to push the boundaries of pharmaceutical research. His work has not only contributed to the advancement of drug development but has also positioned him as a key figure in the industry.
Collaborations
Omodani has collaborated with several esteemed colleagues, including Yasunao Inoue and Fuminori Sato. These partnerships have fostered a collaborative environment that enhances the innovation process within the company.
Conclusion
In summary, Tomoki Omodani's contributions to the field of pharmaceuticals through his patents and collaborative efforts highlight his role as an influential inventor. His work continues to pave the way for advancements in drug development and innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
